IRadimed

IRadimed EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of IRadimed (IRMD) as of Nov 7, 2026 is 24.04 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 22.34 % — a change of 7.60% (higher).

EBIT/Assets

24.04 %

YoY

7.60%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of IRadimed is 2025 24.04 % . Operating Income to Assets Ratio (EBIT/Assets) of IRadimed was 2024 22.34 % . It decreases by 7.60% higher compared to the previous year.

The IRadimed EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
12.39 USD
Jan 1, 2019
12.96 USD
Jan 1, 2020
-1.06 USD
Jan 1, 2021
11.85 USD
Jan 1, 2022
18.28 USD
Jan 1, 2023
21.74 USD
Jan 1, 2024
22.34 USD
Jan 1, 2025
24.04 USD
The IRadimed EBIT/Assets history
YEAREBIT/AssetsYoY
24.04 %+7.60%
22.34 %+2.75%
21.74 %+18.96%
18.28 %+54.28%
11.85 %-1,213.38%
-1.06 %-108.21%
12.96 %+4.56%
12.39 %+276.27%
3.29 %-88.78%
29.36 %-10.12%
32.67 %+148.36%
13.15 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

IRadimed Stock analysis

What does IRadimed do? IRadimed Corp is an American company specializing in the development, manufacturing, and marketing of advanced medical technology products. The company was founded in 1992 and is headquartered in Winter Springs, Florida. It was founded to meet the need for advanced and precise medical devices used in intensive care. In recent years, the company has focused on the development of components and accessory products for magnetic resonance imaging (MRI) used in radiology and oncology. IRadimed Corp is known for its innovative and technologically advanced approach to the medical technology industry. The company prioritizes research and development and collaborates closely with clinics, hospitals, and medical facilities to provide the best solutions for patient care. It has a strong distribution network that allows its products to be distributed worldwide, particularly in the United States, Europe, and Asia. The company offers a wide range of medical devices and accessory products used in radiology, oncology, and other medical fields. Its specialty lies in manufacturing components and accessories for MRI. These include MRI-compatible infusion pumps, patient monitoring devices, ventilation devices, and coil arrays designed for imaging the skull and spine, as well as breast and prostate imaging. In summary, IRadimed Corp is a leading provider of medical devices and accessories for radiology, oncology, and other specialized fields. Its focus on MRI-compatible devices and accessories, as well as its collaborative approach with medical facilities, sets it apart in the industry. The company prides itself on innovation and technological advancement, offering a wide range of products tailored to the needs of patients and medical professionals. IRadimed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IRadimed stock

Operating Income to Assets Ratio (EBIT/Assets) of IRadimed is 24.04 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of IRadimed changed from 22.34 % to 24.04 %, representing a 7.60% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) IRadimed since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s IRadimed with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — IRadimed

All Key Metrics — IRadimed